Dr. Sher Joined VBL in 2006. She was previously Head of QC Laboratories, Operations Division at Teva, and QC/QA Director at InterPharm, Subsidiary of Ares-Serono gaining 15 years of drug development and regulatory experience. Dr. Sher holds a Ph.D. from the Hebrew University, Israel and completed a post-doctoral fellowships at the Hebrew University, Jerusalem and at Rutgers University, New Jersey, U.S.
drug development